[go: up one dir, main page]

CY1110368T1 - Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη - Google Patents

Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη

Info

Publication number
CY1110368T1
CY1110368T1 CY20081101016T CY081101016T CY1110368T1 CY 1110368 T1 CY1110368 T1 CY 1110368T1 CY 20081101016 T CY20081101016 T CY 20081101016T CY 081101016 T CY081101016 T CY 081101016T CY 1110368 T1 CY1110368 T1 CY 1110368T1
Authority
CY
Cyprus
Prior art keywords
roflumilast
formatoterol
synthetic combination
synthetic
combination
Prior art date
Application number
CY20081101016T
Other languages
English (en)
Inventor
Rolf Beume
Daniela Bundschuh
Degenhard Marx
Christian Weimar
Stefan-Lutz Wollin
Original Assignee
Nycomed Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Gmbh filed Critical Nycomed Gmbh
Publication of CY1110368T1 publication Critical patent/CY1110368T1/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/08—Bronchodilators

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Η εφεύρεση αφορά συνδυασμένη χορήγηση ροφλουμιλάστης και R,R-φορμοτερόλης δια την θεραπευτική αγωγή παθήσεων των αναπνευστικών οδών.
CY20081101016T 2002-11-27 2008-09-17 Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη CY1110368T1 (el)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02026504 2002-11-27
EP03780056A EP1567140B1 (en) 2002-11-27 2003-11-26 Synergistic combination comprising roflumilast and (r,r)-formoterol

Publications (1)

Publication Number Publication Date
CY1110368T1 true CY1110368T1 (el) 2015-04-29

Family

ID=32338001

Family Applications (1)

Application Number Title Priority Date Filing Date
CY20081101016T CY1110368T1 (el) 2002-11-27 2008-09-17 Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη

Country Status (31)

Country Link
US (1) US20060199865A1 (el)
EP (1) EP1567140B1 (el)
JP (1) JP2006508993A (el)
KR (1) KR20050094810A (el)
CN (1) CN1713902A (el)
AT (1) ATE399544T1 (el)
AU (1) AU2003288169B8 (el)
BR (1) BR0316475A (el)
CA (1) CA2506956C (el)
CO (1) CO5690571A2 (el)
CY (1) CY1110368T1 (el)
DE (1) DE60321954D1 (el)
DK (1) DK1567140T3 (el)
EA (1) EA009990B1 (el)
ES (1) ES2309374T3 (el)
HR (1) HRP20050580B1 (el)
IL (1) IL168307A (el)
IS (1) IS2576B (el)
MA (1) MA27538A1 (el)
ME (1) ME00488B (el)
MX (1) MXPA05005438A (el)
NO (1) NO334148B1 (el)
NZ (1) NZ540658A (el)
PL (1) PL214869B1 (el)
PT (1) PT1567140E (el)
RS (1) RS51082B (el)
SI (1) SI1567140T1 (el)
TN (1) TNSN05130A1 (el)
UA (1) UA83017C2 (el)
WO (1) WO2004047828A1 (el)
ZA (1) ZA200503307B (el)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MY140561A (en) 2002-02-20 2009-12-31 Nycomed Gmbh Dosage form containing pde 4 inhibitor as active ingredient
US7470791B2 (en) 2003-03-10 2008-12-30 Nycomed Gmbh Process for the preparation of roflumilast
EP1861074B1 (en) 2005-03-16 2013-04-24 Takeda GmbH Taste masked dosage form containing roflumilast
WO2013077830A1 (en) * 2011-11-25 2013-05-30 Mahmut Bilgic Synergistilly active combinations of roflumilast and carmoterol
CN103784443A (zh) * 2014-02-18 2014-05-14 青岛市城阳区人民医院 一种包含沙美特罗和罗氟司特的药物组合产品

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5795564A (en) * 1991-04-05 1998-08-18 Sepracor, Inc. Methods and compositions for treating pulmonary disorders using optically pure (R,R)-formoterol
DK0938467T3 (da) * 1996-11-11 2002-10-07 Sepracor Inc Fremgangsmåde til fremstilling af optisk rene isomerer af formoterol
CA2276429C (en) * 1997-02-17 2007-06-19 Byk Gulden Lomberg Chemische Fabrik Gmbh Compositions for the treatment of ards or irds containing 3-(cyclopropylmethoxy)-n-(3,5-dichloro-4-pyridinyl)-4-(difluoromethoxy)benzamide and lung surfactant
US6624181B1 (en) * 1997-02-28 2003-09-23 Altana Pharma Ag Synergistic combination
PT975347E (pt) * 1997-02-28 2008-05-23 Nycomed Gmbh Combinação sinérgica de inibidores da pde e agonistas da adenilato ciclase ou agonistas da guanil ciclise
JP2002523452A (ja) * 1998-08-26 2002-07-30 スミスクライン・ビーチャム・コーポレイション 肺疾患の治療方法
US6303145B2 (en) * 1999-05-10 2001-10-16 Sepracor Inc. (S,R) formoterol methods and compositions
AU777012B2 (en) * 1999-08-21 2004-09-30 Takeda Gmbh Synergistic combination of PDE inhibitors and beta 2 adrenoceptor agonist
GB0103630D0 (en) * 2001-02-14 2001-03-28 Glaxo Group Ltd Chemical compounds
DE60224172T2 (de) * 2001-03-22 2008-12-04 Glaxo Group Ltd., Greenford Formanilid-derivative als beta2-adrenorezeptor-agonisten
CN1302007C (zh) * 2001-04-30 2007-02-28 葛兰素集团有限公司 具有抗炎性的在17.α位上具有环酯基的雄甾烷的17.β.－硫代羧酸酯衍生物

Also Published As

Publication number Publication date
EP1567140A1 (en) 2005-08-31
HRP20050580A2 (en) 2006-08-31
MXPA05005438A (es) 2005-08-03
US20060199865A1 (en) 2006-09-07
CO5690571A2 (es) 2006-10-31
HK1081862A1 (en) 2006-05-26
KR20050094810A (ko) 2005-09-28
NO334148B1 (no) 2013-12-16
ME00488B (me) 2011-10-10
WO2004047828A1 (en) 2004-06-10
AU2003288169A1 (en) 2004-06-18
UA83017C2 (uk) 2008-06-10
DE60321954D1 (de) 2008-08-14
AU2003288169B2 (en) 2010-01-07
CA2506956C (en) 2012-10-02
PL214869B1 (pl) 2013-09-30
TNSN05130A1 (en) 2007-05-14
BR0316475A (pt) 2005-10-11
IL168307A (en) 2010-12-30
NO20053023L (no) 2005-06-20
ES2309374T3 (es) 2008-12-16
CN1713902A (zh) 2005-12-28
EA009990B1 (ru) 2008-04-28
SI1567140T1 (sl) 2008-12-31
EP1567140B1 (en) 2008-07-02
NZ540658A (en) 2007-03-30
CA2506956A1 (en) 2004-06-10
PT1567140E (pt) 2008-09-24
DK1567140T3 (da) 2008-11-03
MA27538A1 (fr) 2005-09-01
IS7899A (is) 2005-06-20
ATE399544T1 (de) 2008-07-15
RS20050383A (sr) 2007-08-03
EA200500865A1 (ru) 2005-12-29
JP2006508993A (ja) 2006-03-16
ZA200503307B (en) 2006-11-29
IS2576B (is) 2010-02-15
RS51082B (sr) 2010-10-31
HRP20050580B1 (hr) 2014-04-11
PL375632A1 (en) 2005-12-12
AU2003288169B8 (en) 2010-08-26

Similar Documents

Publication Publication Date Title
CY1112238T1 (el) Αναστολεις μιτωτικης κινεσινης και μεθοδοι χρησης αυτων
CY1105082T1 (el) Χρηση της φλιβανσepινης στην αγωγη διαταραχων της σεξουαλικης επιθυμιας
DE602004032522D1 (de) Mit n-alkylhydroxamsäuren substituierte isoindolylverbindungen und deren pharmazeutische verwendung
CY1110369T1 (el) Νεος συνεργιστικος συνδυασμος ο οποιος περιεχει ροφλουμιλαστη και φορμοτερολη
CY1106430T1 (el) Φαρμακα για εισπνοη που πepιλαμβανουν βηταμιμητικα και αντιχολινepγικο
SE0303571D0 (sv) Medical product for moisture-sensitive medicaments
CY1109238T1 (el) Δισκιο περιεχον σετιριζινη και ψευδοεφεδρινη
MXPA05012358A (es) Combinacion farmaceutica que comprende modafinilo y otra droga.
EE05357B1 (et) Tablett, mis sisaldab v„hemalt kahte eristatavat segmenti, ning selle kasutamine
CY1110368T1 (el) Συνεργιστικος συνδυασμος ο οποιος περιλαμβανει ροφλουμιλαστη και (r,r)-φορμοτερολη
CY1109666T1 (el) Μεθοδος θεραπειας διαταραχων ξηροφθαλμιας και ραγοειδιτιδας
CY1106552T1 (el) Ενωσεις ισοχρωμανιου για την θεραπεια ανωμαλιων του κνς
UA2986U (uk) Спосіб лікування розсіяного склерозу